![Rebinyn® (Coagulation Factor IX [Recombinant], GlycoPEGylated)](/content/dam/biopharm/rebinyn/global/rebinyn_logo.png){kind=logo}
Rebinyn® is an injectable, extended half-life treatment used to replace clotting Factor IX in people with hemophilia B. It helps people achieve high factor levels and keep them higher, longer.
TAKE CONTROL TO A HIGH LEVEL
Rebinyn®—reach for high factor levels in hemophilia B.
TAKE CONTROL TO A
HIGH LEVEL
Rebinyn®—reach for high factor levels in hemophilia B.
Image for illustrative purposes only.
Image is for illustrative purposes only.
WHAT IS REBINYN®?
IS REBINYN® EFFECTIVE?
Rebinyn® controls bleeds when they happen. In a clinical study, Rebinyn® treated 98% of bleeds in adolescents and adults with 1-2 infusions. 95% of patients and HCPs rated bleed control as successful (defined as excellent or good) in 142 bleeding episodes.
aResults shown are from the on-demand arm of the adolescent/adult clinical study in previously treated patients. In this study, 15 people were treated for on-demand bleeds. In 14 people, there were a total of 143 bleeding episodes.
5X LONGER HALF-LIFE
Rebinyn® provides 5x longer half-life than BeneFIX®.b What could higher factor levels for longer mean for your life with hemophilia B?
bBased upon a phase 1 study comparing 25, 50, and 100 IU/kg doses of Rebinyn® to the same dose of standard half-life rFIX in 7 adults and the same dose of plasma-derived FIX in 8 adults. For Rebinyn®, estimated average FIX activity is adjusted to a dose of 50 IU/kg.
5X LONGER HALF-LIFE
Rebinyn® provides 5x longer half-life than BeneFIX®.b What could higher factor levels for longer mean for your life with hemophilia B?
bBased upon a phase 1 study comparing 25, 50, and 100 IU/kg doses of Rebinyn® to the same dose of standard half-life rFIX in 7 adults and the same dose of plasma-derived FIX in 8 adults. For Rebinyn®, estimated average FIX activity is adjusted to a dose of 50 IU/kg.
YOU’RE NOT ALONE
Hear from others in the hemophilia community and find strength in stories from people like you.
INTERESTED IN TRYING REBINYN®?
To learn more about our free trial prescription program, please call 1-844-668-6732 to speak with a NovoSecure™ Specialist.b
bPatients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product for an FDA-approved indication, and who have commercial insurance may be eligible to receive a limited supply of free product. Patients who participate in any government, state, or federally funded medical or prescription benefit program, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to receive product support. Product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.
WE'RE HERE TO HELP
Wondering about Rebinyn® or living with hemophilia B? Our Hemophilia Community Liaisons (HCLs) are here to answer your questions and connect you with the resources you need.
WE'RE HERE TO HELP
Wondering about Rebinyn® or living with hemophilia B? Our Hemophilia Community Liaisons (HCLs) are here to answer your questions and connect you with the resources you need.
HOW CAN I GET STARTED?
Getting started with Rebinyn® is easy. We’ll take you through the process step by step, so you’ll know what to expect.
CONSIDERING A SWITCH?
See how Factor IX therapies compare on features that matter to you—from storage conditions to infusion time.
